» Articles » PMID: 7777543

Neural-network-based Classification of Cognitively Normal, Demented, Alzheimer Disease and Vascular Dementia from Single Photon Emission with Computed Tomography Image Data from Brain

Overview
Specialty Science
Date 1995 Jun 6
PMID 7777543
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Single photon emission with computed tomography (SPECT) hexamethylphenylethyleneamineoxime technetium-99 images were analyzed by an optimal interpolative neural network (OINN) algorithm to determine whether the network could discriminate among clinically diagnosed groups of elderly normal, Alzheimer disease (AD), and vascular dementia (VD) subjects. After initial image preprocessing and registration, image features were obtained that were representative of the mean regional tissue uptake. These features were extracted from a given image by averaging the intensities over various regions defined by suitable masks. After training, the network classified independent trials of patients whose clinical diagnoses conformed to published criteria for probable AD or probable/possible VD. For the SPECT data used in the current tests, the OINN agreement was 80 and 86% for probable AD and probable/possible VD, respectively. These results suggest that artificial neural network methods offer potential in diagnoses from brain images and possibly in other areas of scientific research where complex patterns of data may have scientifically meaningful groupings that are not easily identifiable by the researcher.

Citing Articles

Comprehensive Review on the Use of Artificial Intelligence in Ophthalmology and Future Research Directions.

Anton N, Doroftei B, Curteanu S, Catalin L, Ilie O, Tarcoveanu F Diagnostics (Basel). 2023; 13(1).

PMID: 36611392 PMC: 9818832. DOI: 10.3390/diagnostics13010100.


The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.

Pavel D, Henderson T, DeBruin S Front Neurol. 2022; 12:749579.

PMID: 35450131 PMC: 9017602. DOI: 10.3389/fneur.2021.749579.


A guide to machine learning for biologists.

Greener J, Kandathil S, Moffat L, Jones D Nat Rev Mol Cell Biol. 2021; 23(1):40-55.

PMID: 34518686 DOI: 10.1038/s41580-021-00407-0.


Applications of machine learning to diagnosis and treatment of neurodegenerative diseases.

Myszczynska M, Ojamies P, Lacoste A, Neil D, Saffari A, Mead R Nat Rev Neurol. 2020; 16(8):440-456.

PMID: 32669685 DOI: 10.1038/s41582-020-0377-8.


Application of Artificial Neural Networks to Identify Alzheimer's Disease Using Cerebral Perfusion SPECT Data.

Swietlik D, Bialowas J Int J Environ Res Public Health. 2019; 16(7).

PMID: 30979022 PMC: 6479441. DOI: 10.3390/ijerph16071303.


References
1.
Kawabata K, Tachibana H, Sugita M, Fukuchi M . A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease. Clin Nucl Med. 1993; 18(4):329-36. DOI: 10.1097/00003072-199304000-00013. View

2.
DAVIS P, Gray L, Albert M, Wilkinson W, Hughes J, HEYMAN A . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease. Neurology. 1992; 42(9):1676-80. DOI: 10.1212/wnl.42.9.1676. View

3.
Hopfield J . Neural networks and physical systems with emergent collective computational abilities. Proc Natl Acad Sci U S A. 1982; 79(8):2554-8. PMC: 346238. DOI: 10.1073/pnas.79.8.2554. View

4.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

5.
Gemmell H, Sharp P, Besson J, Crawford J, Ebmeier K, Davidson J . Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study. J Comput Assist Tomogr. 1987; 11(3):398-402. DOI: 10.1097/00004728-198705000-00005. View